Body Fat Measurement Market Size & Share 2026-2035
Download Free PDF
Report Content
Chapter 1. Research Methodology
1.1 Research Approach
1.2 Quality Commitments
1.2.1 GMI AI Policy & Data Integrity Commitment
1.2.1.1 Source Consistency Protocol
1.3 Research Trail & Confidence Scoring
1.3.1 Research Trail Components
1.3.2 Scoring Components
1.4 Data Collection
1.4.1 Partial List of Primary Sources
1.5 Data Mining Sources
1.5.1 Paid Sources
1.5.1.1 Sources, by Region
1.6 Base Estimates & Calculations
1.6.1 Base Year Calculation
1.7 Forecast Model
1.7.1 Quantified Market Impact Analysis
1.7.1.1 Mathematical Impact of Growth Parameters on Forecast
1.8 Research Transparency Addendum
1.8.1 Source Attribution Framework
1.8.2 Quality Assurance Metrics
1.8.3 Our Commitment to Trust
Chapter 2. Executive Summary
2.1 Industry 360° Synopsis
2.2 Key Market Trends
2.2.1 Product Trends (Chapter 5 — By Product)
2.2.2 End-Use Trends (Chapter 6 — By End Use)
2.2.3 Regional Trends (Chapter 7 — By Region)
2.3 TAM analysis, 2027 - 2035
2.4 CXO Perspectives: Strategic Imperatives
Chapter 3. Industry Insights
3.1 Industry Ecosystem Analysis
3.1.1 Supplier Landscape
3.1.2 Profit Margin
3.1.3 Cost Structure
3.1.4 Value Addition at Each Stage
3.1.5 Factors Affecting the Value Chain
3.1.6 Disruptions
3.2 Industry Impact Forces
3.2.1 Growth Drivers
3.2.1.1 Rising Global Obesity Prevalence & Metabolic Disease Burden Amplifying Clinical Demand for Precise Body Composition Assessment
3.2.1.2 Growing Fitness & Wellness Culture Driving Consumer Adoption of BIA-Based Body Fat Measurement Devices
3.2.1.3 Expanding Clinical Applications of DEXA Systems in Sarcopenia Screening & Geriatric Care Protocols
3.2.1.4 Technological Advancements in Connected & AI-Enabled Body Composition Devices Enhancing Measurement Precision & User Experience
3.2.1.5 Increasing Adoption by Military, Sports Performance & Elite Athletics Programs for Performance Monitoring & Injury Prevention
3.2.2 Industry Pitfalls & Challenges
3.2.2.1 High Capital Cost of Clinical-Grade Systems (DEXA, ADP) Restricting Adoption in Cost-Sensitive Emerging Markets
3.2.2.2 Accuracy Variability & Lack of Standardization Across BIA Device Categories Limiting Clinical Confidence & Interoperability
3.2.2.3 Absence of Insurance Reimbursement Frameworks for Routine Body Composition Testing Constraining Market Demand
3.2.2.4 Regulatory Complexity for Dual-Use Medical Devices Creating Approval Delays & Market Entry Barriers in Key Geographies
3.2.3 Market Opportunities
3.2.3.1 Rising Geriatric Population Globally Creating Sustained Clinical Demand for Sarcopenia & Malnutrition Screening
3.2.3.2 Penetration into Emerging Markets Driven by Expanding Private Healthcare Infrastructure & Rising Disposable Income
3.2.3.3 Integration of AI & Machine Learning Algorithms to Enhance Measurement Accuracy & Enable Predictive Body Composition Analytics
3.2.3.4 Expansion of Telehealth & Remote Patient Monitoring Creating New Use Cases for Connected BIA & Smart Measurement Devices
3.3 Growth Potential Analysis
3.4 Pricing Analysis (Driven by Primary Research)
3.4.1 Historical Price Trend Analysis (Driven by Primary Research)
3.4.2 Pricing Strategy by Player Type (Premium / Value / Cost-plus) (Driven by Primary Research)
3.5 Regulatory Landscape
3.5.1 North America
3.5.2 Europe
3.5.3 Asia Pacific
3.5.4 Latin America
3.5.5 Middle East & Africa
3.6 Porter's Analysis
3.7 PESTEL Analysis
3.8 Trade Data Analysis (Based on Paid Database)
3.8.1 Import/Export Volume & Value Trends (Based on Paid Database)
3.8.2 Key Trade Corridors & Tariff Impact (Based on Paid Database)
3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
3.9.1 AI-Driven Disruption of Existing Business Models
3.9.2 GenAI Use Cases & Adoption Roadmap by Segment
3.9.3 Risks, Limitations & Regulatory Considerations
Chapter 4. Competitive Landscape, 2025
4.1 Introduction
4.2 Company Market Share Analysis
4.2.1 By Region
4.2.1.1 North America
4.2.1.2 Europe
4.2.1.3 Asia Pacific
4.2.1.4 Latin America
4.2.1.5 Middle East & Africa
4.2.2 Market Concentration Analysis
4.3 Competitive Analysis of Major Market Players
4.4 Competitive Positioning Matrix
4.5 Key Developments
4.5.1 Mergers & Acquisitions
4.5.2 Partnerships & Collaborations
4.5.3 New Product Launches
4.5.4 Expansion Plans & Funding
4.6 Company Tier Benchmarking
4.6.1 Tier Classification Criteria & Qualifying Thresholds
4.6.2 Tier Positioning Matrix by Revenue, Geography & Innovation
Chapter 5. Body Fat Measurement Market Estimates & Forecast, By Product (USD Million, 2022–2035)
5.1 BIA Devices
5.1.1 Handheld BIA Devices
5.1.2 Scale-Based BIA Devices
5.1.3 Multi-Frequency Professional BIA Systems
5.2 DEXA Systems
5.2.1 Whole-Body DEXA Scanners
5.2.2 Mobile/Portable DEXA Systems
5.3 Calipers
5.3.1 Manual Skinfold Calipers
5.3.2 Digital Skinfold Calipers
5.4 Air Displacement Plethysmography (ADP)
5.5 Hydrostatic Weighing
5.6 Others
Chapter 6. Body Fat Measurement Market Estimates & Forecast, By End Use (USD Million, 2022–2035)
6.1 Hospitals
6.2 Fitness Centers
6.3 Clinics
6.4 Others
Chapter 7. Body Fat Measurement Market Estimates & Forecast, By Region (USD Million, 2022–2035)
7.1 North America
7.1.1 U.S.
7.1.1.1 By Product
7.1.1.2 By End Use
7.1.2 Canada
7.2 Europe
7.2.1 Germany
7.2.2 UK
7.2.3 France
7.2.4 Italy
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 China
7.3.2 Japan
7.3.3 South Korea
7.3.4 India
7.3.5 Australia
7.3.6 Rest of Asia Pacific
7.4 Latin America
7.4.1 Brazil
7.4.2 Mexico
7.4.3 Argentina
7.4.4 Rest of Latin America
7.5 Middle East & Africa
7.5.1 Saudi Arabia
7.5.2 UAE
7.5.3 South Africa
7.5.4 Rest of Middle East & Africa
Chapter 8. Company Profiles (Driven by Primary Research)
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]
Share Content
Add Citations
Monali Tayade. 2026, November. Body Fat Measurement Market (Report ID: GMI772). Global Market Insights Inc. Retrieved November 13, 2026, from https://www.gminsights.com/toc/details/body-fat-measurement-market
Body Fat Measurement Market
Get a free sample of this report
Body Fat Measurement Market Size
The body fat measurement market was valued at USD 940 million in 2025, is projected to reach USD 1.01 billion in 2026, will advance at a 7.2% CAGR (2026-2035), and is expected to attain USD 1.88 billion by 2035.
The body fat measurement market is moving from episodic wellness tracking toward more routine use in obesity management, clinical nutrition, preventive care, and performance monitoring. Demand increasingly favors platforms that combine reproducible measurement, digital records, and clinically useful interpretation, while buyer choice remains shaped by the tradeoff between precision, workflow fit, and capital intensity.
GMI Analyst View
Our discussions with industry stakeholders indicate that the global body fat measurement market generated USD 874 million in revenues in 2024, providing a size-adjacent foundation for the 2025 base-year assessment and the subsequent forecast trajectory.
Body Fat Measurement Market Trends, Growth Drivers & GMI Forecast Outlook
The market's outlook rests on a widening clinical need to characterize adiposity and metabolic risk more precisely than weight-based screening alone can provide. Professional BIA platforms are broadening access, while DEXA and ADP retain importance where accuracy, longitudinal assessment, and specialized care pathways justify higher procurement and operating requirements.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Obesity care increasingly requires a view of fat distribution, lean mass, and treatment response that body mass index alone cannot supply. That need places body composition measurement within endocrinology, bariatrics, oncology nutrition, geriatric care, and preventive-health workflows, where serial results can influence risk assessment and intervention planning. Once incorporated into a protocol, the device becomes part of a repeatable care process rather than a discretionary wellness purchase.
Pediatric and adolescent care extends this logic into screening and monitoring settings where clinicians need a more nuanced record of changing body composition. Professional BIA is particularly suited to this expansion because it can be deployed across pediatric clinics, institutional health programs, and community settings without the infrastructure burden associated with advanced imaging systems. The resulting demand is additive to adult chronic-disease care rather than dependent on a single clinical application.
Technology is also reshaping the value proposition of clinical BIA. Multi-frequency platforms, integrated analytics, and connected reporting tools support a transition from isolated readings to interpretable longitudinal profiles. This favors suppliers that can pair hardware with software, training, and data-management capabilities, while giving hospitals and research institutions a clearer rationale for replacing older, narrower-function equipment.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Capital intensity narrows the near-term addressable market for full-body precision systems. Facilities evaluating DEXA or ADP must weigh equipment outlays against competing diagnostic priorities, room requirements, technical staffing, and expected utilization. This tends to concentrate advanced-system procurement in academic centers, specialty hospitals, sports-science facilities, and better-funded private providers, while multi-frequency BIA offers a more accessible route for organizations seeking clinically relevant body composition data.
Reimbursement adds a separate utilization challenge. Where body composition assessment is not consistently reimbursed as a distinct clinical service, providers face a weaker basis for recovering equipment and workflow costs through routine patient volume. The effect is strongest in public systems and smaller facilities, where measurement may remain tied to selected specialty pathways rather than becoming standard practice. Calibration obligations and operator competency requirements further favor suppliers with credible service, training, and maintenance support. [2]Medical Outfitters. "DEXA Bone Densitometer Cost Guide." medicaloutfitters.com
GMI Analyst View
We see the central market tension as one of clinical relevance versus practical access. As metabolic monitoring gains importance, BIA is broadening professional adoption where capital budgets and reimbursement cannot sustain higher-intensity modalities, while DEXA and ADP remain essential in specialized settings that value precision and protocol depth.
Body Fat Measurement Market Segment Analysis
By Product
BIA devices accounted for 52.0% of body fat measurement market revenue in 2025 and are projected to generate USD 967 million by 2035. Their reach across consumer wellness, fitness, clinical screening, and research environments gives the category unusual breadth, while multi-frequency systems are expanding the role of BIA in institutional workflows that require more than a basic consumer-scale output.
DEXA systems are projected to generate USD 420 million by 2035 and held a 20.0% revenue share in 2025. Their position rests on high-value clinical and research use cases, including obesity medicine, nutritional assessment, sarcopenia evaluation, and longitudinal monitoring, where imaging-based body composition information can support more comprehensive patient management.
Calipers generated USD 85 million in 2025 and are expected to expand at a 5.3% CAGR (2026-2035). Their continued relevance derives from low acquisition cost, portability, and ease of use in field programs, fitness training, and resource-constrained settings, although demand is increasingly exposed to substitution by connected BIA devices that offer digital records and more repeatable workflows.
ADP systems are projected to reach USD 156 million by 2035 and represented 8.0% of market revenue in 2025. The modality remains differentiated in applications where a radiation-free assessment and controlled testing environment are valuable, particularly in pediatric research, specialized clinical evaluation, and performance-science settings.
Hydrostatic weighing generated USD 47 million in 2025 and is forecast to grow at a 4.9% CAGR (2026-2035). Dedicated water-based infrastructure, technical staffing, and participant burden limit new installations, leaving the category concentrated in established research and elite sports facilities where historical protocols and methodological continuity remain important.
Other products are projected to generate USD 126 million by 2035 and accounted for 6.0% of market revenue in 2025. This category includes emerging approaches such as bioimpedance spectroscopy, hybrid systems, and digitally enabled body-composition platforms, whose commercial prospects depend on successful integration into telehealth, remote monitoring, and broader wellness ecosystems.
By End Use
Hospitals represented 34.0% of body fat measurement market revenue in 2025 and are projected to generate USD 659 million by 2035. Their purchasing decisions are driven by the integration of body composition data into obesity medicine, pre-surgical assessment, oncology nutrition, and geriatric care, where hardware, software, service coverage, and workflow compatibility are typically evaluated together.
Fitness centers are projected to generate USD 530 million by 2035 and are expected to grow at a 6.9% CAGR (2026-2035). Professional BIA systems give gyms and wellness operators a measurable engagement tool that can support memberships, coaching programs, and performance services, while connected reporting helps translate periodic assessments into recurring client interaction.
Clinics generated USD 254 million in 2025 and are expected to account for 27.0% of market revenue by 2035. Specialist endocrinology, bariatric, sports medicine, and nutrition practices favor systems that combine operational practicality with clinically credible output, making this end-use group an important bridge between hospital-grade procurement and consumer-facing wellness channels.
Other end uses are projected to generate USD 190 million by 2035 and accounted for 10.0% of market revenue in 2025. Research institutions, military organizations, academic centers, and corporate wellness programs sustain demand through use cases that prioritize standardized assessment, performance monitoring, and repeatable population-level measurement.
GMI Analyst View
We view the segment structure as a durable two-track market. Accessible BIA systems are widening measurement adoption across fitness and routine clinical use, while DEXA and ADP retain defensible roles where diagnostic confidence, research continuity, and specialized protocols outweigh capital and operational constraints.
Body Fat Measurement Market Regional Analysis
North America Body Fat Measurement Market Analysis
North America is projected to generate USD 679 million by 2035 and is expected to grow at a 6.3% CAGR (2026-2035). The body fat measurement market in the region benefits from established hospital infrastructure, specialist obesity-care pathways, mature fitness channels, and institutional demand from public and military health systems, creating a broad base for both clinical-grade and commercially oriented equipment.
United States
The United States generated USD 312 million in 2025 and is forecast to expand at a 6.2% CAGR (2026-2035). Demand is supported by an installed base across academic medical centers, bariatric programs, specialty outpatient practices, and performance facilities, with connected BIA platforms extending the market beyond high-capital imaging procurement.
Canada
Canada is projected to generate USD 108 million by 2035 and is expected to grow at a 7.0% CAGR (2026-2035). Provincial health priorities, preventive-care initiatives, and urban sports-medicine networks support adoption, while clinical purchasing remains shaped by public-system budgeting and the need for practical, scalable assessment tools.
Europe Body Fat Measurement Market Analysis
Europe is projected to generate USD 464 million by 2035 and accounted for 26.0% of global revenue in 2025. Regulatory expectations under the EU medical-device framework favor suppliers with established compliance capabilities, while obesity medicine, rehabilitation, sports performance, and nutrition research provide multiple institutional routes to demand.
Germany
Germany generated USD 55 million in 2025 and is projected to account for 23.5% of European revenue by 2035. A dense specialist-care network and strong sports-medicine infrastructure support professional BIA and DEXA demand, while established domestic wellness-device distribution broadens access across consumer and semi-professional channels.
United Kingdom
The United Kingdom is projected to generate USD 85 million by 2035 and accounted for 18.0% of European revenue in 2025. Demand is underpinned by hospital and community-health use, specialist weight-management services, and a developed private fitness market that supports professional-grade measurement as a differentiated service.
France
France generated USD 37 million in 2025 and is forecast to grow at a 6.6% CAGR (2026-2035). Clinical use is reinforced by established endocrinology and bone-health pathways, while elite athletics, sports-performance centers, and private practices add demand for professional BIA and specialized assessment systems.
Italy
Italy is projected to generate USD 56 million by 2035 and accounted for 12.3% of European revenue in 2025. Private specialist clinics, rehabilitation practices, and sports-medicine providers are important purchasers, whereas public-hospital capital budgets can make procurement of higher-precision systems more selective.
Spain
Spain generated USD 22 million in 2025 and is projected to account for 8.6% of European revenue by 2035. Growing private-healthcare activity, fitness-industry development, and sports-federation demand provide a diversified commercial base, particularly in urban centers where preventive and performance-oriented services are expanding.
Asia Pacific Body Fat Measurement Market Analysis
Asia Pacific accounted for 30.0% of global revenue in 2025 and is projected to generate USD 646 million by 2035. The body fat measurement market in the region is supported by urbanization, rising metabolic-health attention, health-screening programs, and hospital modernization, although demand patterns vary sharply by national reimbursement structures, provider mix, and equipment affordability.
China
China generated USD 113 million in 2025 and is projected to account for 43.3% of Asia Pacific revenue by 2035. Hospital equipment investment, expanding obesity surveillance, and broader adoption in major cities support demand, while local suppliers are widening access to BIA equipment in cost-sensitive provider segments.
Japan
Japan is projected to generate USD 108 million by 2035 and accounted for 19.9% of Asia Pacific revenue in 2025. Its mature screening culture and institutional familiarity with metabolic-risk evaluation support sustained professional BIA use across health-assessment operators, clinical facilities, and wellness-service providers.
South Korea
South Korea generated USD 34 million in 2025 and is forecast to grow at a 7.8% CAGR (2026-2035). Digital-health infrastructure, domestic expertise in BIA technology, and deployment across hospitals, rehabilitation facilities, and university medical settings support demand for connected, longitudinal body-composition monitoring.
India
India is projected to generate USD 90 million by 2035 and is expected to grow at an 11.2% CAGR (2026-2035). A growing private-hospital network and increasing awareness of metabolic-health risks create a large potential user base, with BIA offering a practical entry point for facilities that cannot readily absorb the capital and operating requirements of DEXA.
Australia
Australia generated USD 17 million in 2025 and is projected to account for 4.8% of Asia Pacific revenue by 2035. High per-capita demand from sports science, research institutions, private hospitals, and obesity-management programs supports a market characterized by advanced use cases rather than sheer population scale.
Latin America Body Fat Measurement Market Analysis
Latin America accounted for 3.6% of global revenue in 2025 and is projected to generate USD 67 million by 2035. Private healthcare development, urban fitness investment, and growing recognition of obesity-related care needs are improving the market's medium-term outlook, although procurement remains sensitive to economic conditions and capital-equipment affordability.
Brazil
Brazil generated USD 19 million in 2025 and is projected to account for 58.2% of Latin American revenue by 2035. Large urban populations, commercial fitness chains, sports medicine, and private-hospital expansion support demand across both accessible BIA products and selected clinical-grade systems.
Mexico
Mexico is projected to generate USD 17 million by 2035 and accounted for 26.5% of Latin American revenue in 2025. Private hospitals, sports organizations, and boutique fitness operators provide key demand channels, while preventive-care expansion supports broader awareness of body-composition assessment.
Middle East & Africa Body Fat Measurement Market Analysis
Middle East & Africa is projected to generate USD 31 million by 2035 and is expected to grow at a 9.1% CAGR (2026-2035). Demand is concentrated in premium, institution-led procurement, particularly where government health investment, new hospital capacity, preventive-care strategies, and medical-tourism activity create a viable environment for clinical BIA and DEXA deployment.
Saudi Arabia
Saudi Arabia is projected to generate USD 11 million by 2035 and is forecast to grow at a 10.6% CAGR (2026-2035). Public hospital expansion, preventive-health priorities, and procurement through major government and military health facilities create the principal route to market, supplemented by private providers in major metropolitan areas.
UAE
The UAE generated USD 3 million in 2025 and is projected to account for 25.8% of Middle East & Africa revenue by 2035. Private healthcare, wellness services, and medical-tourism activity support high utilization potential for body-composition technologies, particularly in premium hospital and specialized wellness settings.
South Africa
South Africa generated USD 2 million in 2025 and is projected to account for 12.9% of Middle East & Africa revenue by 2035. Private healthcare networks and university sports-science departments remain central buyers, while uneven access to capital equipment constrains wider penetration beyond established urban care and research centers.
GMI Analyst View
We expect regional opportunity to become increasingly differentiated by procurement model rather than by population scale alone. Asia Pacific offers the broadest expansion runway, while Middle East & Africa presents concentrated premium opportunities; both require market-specific channel, service, and clinical-partnership strategies rather than a uniform regional approach.
Body Fat Measurement Market Share & Competitive Landscape
The body fat measurement market share structure is moderately concentrated: the top five companies collectively held 49.8% of global revenue in 2025, while other suppliers accounted for 50.2%. Competition therefore combines established global platforms with regional specialists, diagnostic-equipment providers, and wellness-device manufacturers. Clinical validation, installed-base service, digital analytics, institutional distribution, and modality-specific expertise are important differentiators.
InBody held a 14.3% global revenue share in 2025. Its position is supported by a broad multi-frequency BIA portfolio spanning clinical, fitness, rehabilitation, and institutional settings, together with software and data-management capabilities that strengthen customer relationships beyond the initial device sale.
Tanita Corporation held a 13.3% global revenue share in 2025. The company's institutional presence in health-screening, hospital, and sports-performance environments supports its role in professional body-composition assessment, particularly in markets where established screening relationships and local distribution are decisive.
Beurer held an 8.6% global revenue share in 2025. Its connected health ecosystem and consumer-to-semi-professional positioning give it a differentiated route to market, linking measurement devices with digital wellness tools and helping sustain engagement outside high-acuity clinical applications.
Omron Healthcare competes through its broader health-monitoring footprint and distribution reach across clinical, home-health, and consumer channels. Its ability to connect body-composition measurement with adjacent monitoring categories can strengthen its relevance where providers and consumers seek integrated health-management experiences.
COSMED occupies a specialized position in metabolic, cardiopulmonary, and body-composition diagnostics. Its BOD POD ADP offering and complementary clinical-performance portfolio are relevant to research, pediatric, and high-precision assessment environments where modality expertise and workflow integration are especially important.
DMS Imaging serves medical-grade DEXA demand through platforms that combine bone densitometry and body-composition capabilities. This positioning is relevant to hospitals and sports-medicine providers seeking to consolidate imaging-based assessment within a single clinical workflow.
GE HealthCare Technologies participates through DEXA-based bone-density and skeletal-imaging platforms. Existing hospital relationships and radiology-channel access create an advantage where body-composition functionality is considered alongside broader imaging and diagnostic procurement requirements.
Hologic maintains a meaningful role in DEXA-based body-composition assessment through its skeletal-health platform portfolio and associated software capabilities. Its clinical footprint positions the company to address obesity medicine, research, and specialty-care requirements where imaging-based assessment is preferred.
AccuFitness, L'Acn Srl., and Maltron International address more specialized portions of the market, including skinfold assessment, clinical nutrition, medical research, and sports medicine. Their relevance reflects the persistence of application-specific demand that is not fully served by broad consumer-wellness or hospital-imaging portfolios.
Recent Industry Developments
In September 2025, COSMED completed its acquisition of Bioparhom, adding bio-impedance spectroscopy capabilities to its body-composition and metabolic-assessment portfolio. The transaction expands COSMED's ability to address clinical nutrition, metabolic diagnostics, and sports-performance use cases across complementary measurement modalities. [3]COSMED. "COSMED Acquires Bioparhom to Strengthen Its Leadership in Body Composition and Metabolic Assessment." cosmed.com
In October 2025, Naver announced a strategic partnership with InBody and acquired an 8.5% equity stake in the company. The partnership is intended to combine AI and health-data capabilities with body-composition analysis to develop personalized health-management services across online and offline settings. [4]Yonhap News Agency. "Naver Partners with InBody to Enter Global Digital Health Care Market." en.yna.co.kr
In October 2025, Hologic announced a definitive agreement to be acquired by funds managed by Blackstone and TPG for up to USD 79 per share, with an enterprise value of up to USD 18.3 billion. The proposed transaction could influence capital allocation priorities across Hologic's skeletal-health and body-composition product lines. [5]Hologic, Inc. "Hologic to be Acquired by Blackstone and TPG for up to $79 per Share." hologic.com
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.